
OR31-1 Sodium-Glucose Co-Transporter-2 Inhibitors and the Risk of Diabetic Ketoacidosis: Clinical and Biochemical Characteristics of 21 Cases
Author(s) -
George A. Stamatiades,
Gracia Viana,
Mehreen Elahee,
Sachin Majumdar
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-or31-1
Subject(s) - diabetic ketoacidosis , medicine , canagliflozin , empagliflozin , diabetes mellitus , ketoacidosis , dapagliflozin , vomiting , nausea , glycosuria , intensive care medicine , pediatrics , endocrinology , type 2 diabetes , type 1 diabetes